Nanjing Vishee Medical Technology Co Ltd (688580) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Nanjing Vishee Medical Technology Co Ltd (688580) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥42.79 Million ≈ $6.26 Million USD) by net assets (CN¥1.66 Billion ≈ $242.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Nanjing Vishee Medical Technology Co Ltd - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Nanjing Vishee Medical Technology Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 688580 liabilities breakdown for a breakdown of total debt and financial obligations.
Nanjing Vishee Medical Technology Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nanjing Vishee Medical Technology Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Dazzle Fashion Co Ltd
SHG:603587
|
0.032x |
|
New Pacific Metals Corp
TO:NUAG
|
-0.008x |
|
Guangdong Vanward New Electric Co Ltd
SHE:002543
|
-0.005x |
|
Coretronic
TWO:5371
|
0.016x |
|
Central Pacific Financial Corp
NYSE:CPF
|
0.038x |
|
SEC Electric Mach Co Ltd
SHG:603988
|
0.015x |
|
Itcen Co. Ltd
KQ:124500
|
0.210x |
|
Metropolitan Bank Holding
NYSE:MCB
|
0.043x |
Annual Cash Flow Conversion Efficiency for Nanjing Vishee Medical Technology Co Ltd (2013–2024)
The table below shows the annual cash flow conversion efficiency of Nanjing Vishee Medical Technology Co Ltd from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see 688580 stock market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥1.63 Billion ≈ $238.15 Million |
CN¥118.29 Million ≈ $17.31 Million |
0.073x | -11.90% |
| 2023-12-31 | CN¥1.63 Billion ≈ $238.05 Million |
CN¥134.20 Million ≈ $19.64 Million |
0.082x | +46.34% |
| 2022-12-31 | CN¥1.53 Billion ≈ $223.67 Million |
CN¥86.17 Million ≈ $12.61 Million |
0.056x | -45.08% |
| 2021-12-31 | CN¥1.53 Billion ≈ $224.34 Million |
CN¥157.37 Million ≈ $23.03 Million |
0.103x | +19.93% |
| 2020-12-31 | CN¥1.41 Billion ≈ $206.47 Million |
CN¥120.76 Million ≈ $17.67 Million |
0.086x | -84.58% |
| 2019-12-31 | CN¥254.86 Million ≈ $37.29 Million |
CN¥141.47 Million ≈ $20.70 Million |
0.555x | +26.84% |
| 2018-12-31 | CN¥196.16 Million ≈ $28.70 Million |
CN¥85.84 Million ≈ $12.56 Million |
0.438x | +28.26% |
| 2017-12-31 | CN¥153.42 Million ≈ $22.45 Million |
CN¥52.35 Million ≈ $7.66 Million |
0.341x | +30.17% |
| 2016-12-31 | CN¥118.20 Million ≈ $17.30 Million |
CN¥30.98 Million ≈ $4.53 Million |
0.262x | +10.44% |
| 2015-12-31 | CN¥106.25 Million ≈ $15.55 Million |
CN¥25.22 Million ≈ $3.69 Million |
0.237x | -2.51% |
| 2014-12-31 | CN¥61.64 Million ≈ $9.02 Million |
CN¥15.01 Million ≈ $2.20 Million |
0.243x | +14.83% |
| 2013-12-31 | CN¥38.81 Million ≈ $5.68 Million |
CN¥8.23 Million ≈ $1.20 Million |
0.212x | -- |
About Nanjing Vishee Medical Technology Co Ltd
Nanjing Vishee Medical Technology Co., Ltd provides rehabilitation meditation products and solutions in China and internationally. The company offers MagNeuro, a transcranial magnetic stimulation (TMS) for use in anxiety disorders, movement disorders, and ADHD applications; MagNeuro ONE, a TMS therapy system with navigation for use in anxiety disorders applications; and MagBelle, a pelvic floor m… Read more